Vinblastine Sulfate Powder
NDC Package 48954-588-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Vinblastine Sulfate powders is vinblastine is used to treat cancer. This formulation utilizes a powder delivery system. Marketed by Fine Chemicals Corporation (pty) Ltd., this product is identified by NDC 48954-588.

Identification & Billing

NDC Package Code
48954-588-07
Package Description
1 BOTTLE, GLASS in 1 BAG / 374.5 g in 1 BOTTLE, GLASS
Product Code
48954-588
11-Digit Billing Format
48954058807

Clinical Specifications

Proprietary Name
Vinblastine Sulfate
Non-Proprietary Name
Vinblastine Sulfate
Substance Name
Vinblastine Sulfate
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
VINBLASTINE SULFATE 1 g/g
Usage Information
Vinblastine is used to treat cancer. It works by slowing or stopping the growth of cancer cells.

Regulatory & Marketing

Labeler Name
Fine Chemicals Corporation (pty) Ltd.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
05-12-1982
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (48954-588). Click a package code to view its specific billing and regulatory data.

48954-588-00
1 BOTTLE, GLASS in 1 BAG / 180 g in 1 BOTTLE, GLASS
48954-588-01
1 BOTTLE, GLASS in 1 BAG / 100 g in 1 BOTTLE, GLASS
48954-588-02
1 BOTTLE, GLASS in 1 BAG / 86.03 g in 1 BOTTLE, GLASS
48954-588-03
1 BOTTLE, GLASS in 1 BAG / 114 g in 1 BOTTLE, GLASS
48954-588-04
1 BOTTLE, GLASS in 1 BAG / 100 g in 1 BOTTLE, GLASS
48954-588-05
1 BOTTLE, GLASS in 1 BAG / 126 g in 1 BOTTLE, GLASS
48954-588-06
1 BOTTLE, GLASS in 1 BAG / 430.4 g in 1 BOTTLE, GLASS

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 48954-588-07 identifies a specific commercial package of 1 bottle, glass in 1 bag / 374.5 g in 1 bottle, glass of Vinblastine Sulfate (UNFINISHED drug), a bulk ingredient labeled by Fine Chemicals Corporation (pty) Ltd.. This powder is formulated for use and contains vinblastine sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fine Chemicals Corporation (pty) Ltd. on May 12, 1982. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Vinblastine is used to treat cancer. It works by slowing or stopping the growth of cancer cells.

How is this Fine Chemicals Corporation (pty) Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 48954058807. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
48954-588-07
11-Digit CMS (5-4-2)
48954-0588-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.